bupivacaine has been researched along with Cancer of Cecum in 1 studies
Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.
Excerpt | Relevance | Reference |
---|---|---|
"A patient with disseminated cancer pain failed to obtain pain relief despite the intravenous infusion of hydromorphone at a rate equivalent to over 7 g of morphine/day." | 3.67 | Failure of epidural opioid to control cancer pain in a patient previously treated with massive doses of intravenous opioid. ( Cousins, MJ; Tanelian, DL, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tanelian, DL | 1 |
Cousins, MJ | 1 |
1 other study available for bupivacaine and Cancer of Cecum
Article | Year |
---|---|
Failure of epidural opioid to control cancer pain in a patient previously treated with massive doses of intravenous opioid.
Topics: Adenocarcinoma; Bupivacaine; Cecal Neoplasms; Clonidine; Female; Humans; Hydromorphone; Infusions, I | 1989 |